NEW YORK (PRWEB) August 04, 2022
The Healthcare Technology Report is pleased to announce The Top 100 Healthcare Technology Companies of 2022. The awardees on this year’s list represent the absolute best in the healthcare technology space. From companies like Novartis with more than 100,000 team members around the globe, to numerous smaller startups with just a few dozen employees in a single office, these companies are changing the face of the industry. They are leveraging their considerable talent to find innovative solutions to the most pressing issues in healthcare, and they are saving countless lives and extending healthspans in the process.
A few of this year’s awardees include Hologic, whose growth across breast and skeletal health, diagnostic solutions, and GYN surgical solutions is driven by the clinically proven ability of its products to detect, diagnose, and treat illnesses and other health conditions earlier and better; Integra LifeSciences, which offers a broad portfolio of products and solutions for dural access and repair, cerebral spinal fluid management, and neuro-critical care; and Axtria, whose best-in-class cloud-based analytics platforms have leveraged AI and machine learning to help life sciences operators make the most of their data for the benefit of their clients.
The top 100 companies this year represent a range of specialties, from genomics to pharmaceuticals, lab testing, therapeutics, data analysis, and much more. What they have in common is the impact they are having on patients’ lives, whether through direct treatment or by providing advanced, game-changing products and services to treatment providers. They are driving the industry forward and creating an environment in which better care for all is possible. Please join us in celebrating The Top 100 Healthcare Technology Companies of 2022.
Novartis, Stryker, Edwards Lifesciences, Centura Health, Hologic, Access Healthcare, CitiusTech, Integra LifeSciences, JAZZ Pharmaceuticals, Axtria, Horizon Therapeutics, Leica Biosystems, Modere, Penumbra, Practo, Tempus, Verily, Carbon Health, GHX, TELUS Health, Tandem Diabetes Care, Cue Health, Certara, Thrive, Organogenesis, Alto Pharmacy, Ascom, DispatchHealth, Weave, Ro, Merative, Komodo Health, Zynex, Tebra, Telstar, MedGenome, Wellspect Healthcare, Somatus, Sophia Genetics, Flo Health, H1, Intra-Cellular Therapies, Augmedix, DentalMonitoring, Meditab Software, Immunocore, Roivant Sciences, 98point6, Seven Bridges, ExactCare Pharmacy, Helix, LeanTaaS, Clinical ink, InterVenn Biosciences, Omada Health, Quanticate, BillionToOne, Kaia Health, Biodesix, Exagen, Big Health, Accelerate Diagnostics, Avalon Healthcare Solutions, Enable Injections, Pluri Inc., Krystal Biotech, Precision Medical Products, Hallmark Health Care Solutions, ImagineSoftware, BioIQ, Qventus, Sino Biological, Sedera, Sony Biotechnology, Sotera Health, Precision Value & Health, Intarcia Therapeutics, Caption Health, Transcenta, Tosoh Bioscience, Xoran Technologies, Ocimum Biosolutions, RXNT, Providence Medical Technology, Canary Medical, Cynerio, Bright.md, Exponent Health, HitGen, OriGen Biomedical, Force Therapeutics, Relias, D2 Solutions, renegade.bio, Patagonia Health, Lazurite, Vizzia Technologies, Commonwealth Diagnostics International, Fisher Wallace Laboratories, XIL Health.
The full article can be read at https://thehealthcaretechnologyreport.com/
About The Healthcare Technology Report
The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.